<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03990948</url>
  </required_header>
  <id_info>
    <org_study_id>S62085</org_study_id>
    <nct_id>NCT03990948</nct_id>
  </id_info>
  <brief_title>Hepcidin Behavior in Patients With Obesity and Bariatric Surgery</brief_title>
  <acronym>HOBS</acronym>
  <official_title>Hepcidin Behavior in Patients With Obesity and Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron deficiency is one of the most common nutritional problems observed in patients with&#xD;
      obesity and after bariatric surgery. From a therapeutic point of view, iron deficiency can&#xD;
      lead to iron deficiency anemia. Iron supplementation carries the risk of exacerbating&#xD;
      infections, altering the gut microbiome and iron overload. Therefore, it would be beneficial&#xD;
      to use iron supplementation only in truly iron deficient patients. To date, different studies&#xD;
      have observed that hepcidin could be a possible indicator of iron status and absorption in&#xD;
      different patient populations. Furthermore, it could be used to distinguish anemia due to&#xD;
      iron deficiency from inflammation and globin disorder related anemia. How hepcidin&#xD;
      concentrations variate in patients with obesity and after bariatric surgery remains unsure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During the visit in the obesity clinic, eligible patients will be approached for&#xD;
      participation by the sub-investigator. Interested patients will receive information regarding&#xD;
      the study and receive the information sheet containing the informed consent form. After&#xD;
      signing the informed consent form, general information will be collected regarding medical&#xD;
      and demographic data using a short questionnaire. Additional questionnaires regarding&#xD;
      demographics and menstrual cycle will be collected. Anthropometric measurements will be&#xD;
      collected for the determination of the length, weight, hip circumference, waist circumference&#xD;
      and body composition. Finally, blood samples will be collected for the determination of iron&#xD;
      and inflammation related markers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2019</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum hepcidin concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Serum hepcidin concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Hemoglobin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean corpuscular volume</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Mean corpuscular volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Iron concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Iron concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ferritin concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Ferritin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transferrin concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Transferrin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transferrin saturation</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Transferrin saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin B12 concentration</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Vitamin B12 concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate (RBC level)</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Folate (RBC level)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate (serum level)</measure>
    <time_frame>Study visit 1 day</time_frame>
    <description>Folate (serum level)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Hepcidin</condition>
  <arm_group>
    <arm_group_label>Patients with obesity</arm_group_label>
    <description>In 100 patients with obesity, blood samples will be collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with a Sleeve Gastrectomy</arm_group_label>
    <description>In 100 patients with a Sleeve Gastrectomy, blood samples will be collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with a Roux-en-Y Gastric Bypass</arm_group_label>
    <description>In 100 patients with a Roux-en-Y Gastric Bypass, blood samples will be collected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sample collection</description>
    <arm_group_label>Patients with a Roux-en-Y Gastric Bypass</arm_group_label>
    <arm_group_label>Patients with a Sleeve Gastrectomy</arm_group_label>
    <arm_group_label>Patients with obesity</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with obesity, patients with a Sleeve Gasterctomy or patients with a Roux-en-Y&#xD;
        Gastric Bypass&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient has to be 18 years or older&#xD;
&#xD;
          -  Written informed consent has to be obtained after being informed on all aspects of the&#xD;
             study&#xD;
&#xD;
          -  The patient has a BMI &gt; 30 kg/m² OR There has to be at least one year between the&#xD;
             primary RYGB and the participation in the study OR There has to be at least one year&#xD;
             between the primary SG and the participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients younger than 18 years old&#xD;
&#xD;
          -  Women who are pregnant or are breastfeeding&#xD;
&#xD;
          -  Post-menopausal women, defined as at least 6 months of amenorrhea after the final&#xD;
             menstrual period&#xD;
&#xD;
          -  Inability to follow the procedures of the studies due to language problems&#xD;
&#xD;
          -  Patients who have had more than one bariatric surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nele Steenackers, MSc</last_name>
    <phone>0032 016 34 49 13</phone>
    <email>nele.steenackers@kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nele Steenackers</last_name>
      <phone>0032 16 34 49 13</phone>
      <email>nele.steenackers@kuleuven.be</email>
    </contact>
    <investigator>
      <last_name>Bart Van der Schueren, Prof. MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Mertens, Prof. MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Lannoo, Prof. MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christophe Matthys, Prof. Dr. Ir.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nele Steenackers</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hilde Morobé</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 17, 2019</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

